Is there an indirect way to invest in Impact Therap-b?

Direct listed exposure is available, so an indirect proxy is usually unnecessary.

Does Impact Therap-b have a stock symbol?

The stock symbol is 7630.HK on HKSE.

Impact Therap-b

Status: Publicly traded

Direct answer

Impact Therap-b is publicly traded on HKSE under the ticker 7630.HK.

IMPACT Therapeutics, Inc., a biotechnology company, researches and develops synthetic lethality (SL)-based precision anti-cancer therapies in China and internationally. The company offers a product, (IMP4297) Senaparib, a PARP1/2 inhibitor that is used for 1L maintenance therapy for ovarian cancer (OC). Its pipeline products includes IMP1734, a next-generation poly (ADP-ribose) polymerase (PARP)1 selective inhibitor...

Can you invest in Impact Therap-b?

Yes. Impact Therap-b is publicly traded on HKSE under the ticker 7630.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Impact Therap-b

Detailed equity research is provided by MarketSnap.